FDA Inspection 1321654 — Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited)

Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited) — FEI 3005674618

The FDA completed an inspection of Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited) on May 8, 2026 in Gurugram. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 8, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gurugram (India)